Table 3.
Comparison | R-value | P-value |
---|---|---|
[TNF-alpha] vs. [Norepinephrine] | −0.02 | 0.83 |
[TNF-alpha] vs. [Epinephrine] | 0.24 | 0.04 |
[TNF-alpha] vs. Phase II_L Response | 0.15 | 0.21 |
[TNF-alpha] vs. Cardiac R-R Interval | −0.04 | 0.72 |
[IL-6] vs [Norepinephrine] | −0.02 | 0.84 |
[IL-6] vs. [Epinephrine] | 0.29 | 0.02 |
[IL-6] vs. Phase II_L Response | 0.44 | < 0.0001* |
[IL-6] vs. Cardiac R-R Interval | −0.22 | 0.06 |
[CRP] vs. [Norepinephrine] | −0.10 | 0.40 |
[CRP] vs. [Epinephrine] | 0.11 | 0.33 |
[CRP] vs. Phase II_L Response | 0.13 | 0.28 |
[CRP] vs. Cardiac R-R Interval | −0.14 | 0.24 |
designates those associations which reached statistical significance after correction for multiple comparisons.